1. Home
  2. WFF vs HOTH Comparison

WFF vs HOTH Comparison

Compare WFF & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WF Holding Limited Ordinary Shares

WFF

WF Holding Limited Ordinary Shares

N/A

Current Price

$2.05

Market Cap

10.2M

ML Signal

N/A

Logo Hoth Therapeutics Inc.

HOTH

Hoth Therapeutics Inc.

HOLD

Current Price

$1.36

Market Cap

11.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WFF
HOTH
Founded
1984
2017
Country
Malaysia
United States
Employees
142
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.2M
11.7M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
WFF
HOTH
Price
$2.05
$1.36
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
13.8K
7.9M
Earning Date
05-24-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.69
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$0.49
52 Week High
$29.22
$2.12

Technical Indicators

Market Signals
Indicator
WFF
HOTH
Relative Strength Index (RSI) 55.87 84.55
Support Level $0.38 $1.28
Resistance Level $2.08 $1.47
Average True Range (ATR) 0.18 0.10
MACD -0.02 0.05
Stochastic Oscillator 57.38 81.19

Price Performance

Historical Comparison
WFF
HOTH

About WFF WF Holding Limited Ordinary Shares

WF Holding Ltd is a manufacturer of FRP products based in Malaysia. It has been providing high-quality and durable FRP products to various industries, including, among others, chemical processing, water and wastewater treatment, and power generation. Its products range from tanks, pipes, ducts, gratings, and other custom-made FRP products. Its manufacturing capabilities allow the company to design and fabricate products that meet the specific needs of its clients, ensuring high-quality and reliable performance. Geographically, the company generates the majority of its revenue from Australia.

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA). Its current assets are focused in treating cancer, skin toxicities, Alzheimer's, and weight loss.

Share on Social Networks: